{"title":"The bamboo ceiling: An underrecognized barrier for Asians and Asian Americans in academic medicine.","authors":"So Hyun Jeon, Anson O'Young, Ho-Man Yeung","doi":"10.1016/j.amjms.2025.09.013","DOIUrl":"10.1016/j.amjms.2025.09.013","url":null,"abstract":"","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145088829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Changes in perceived neighborhood environments by COVID-19: A nationwide Korean survey.","authors":"Ki Dong Ko, In Cheol Hwang, Hong Yup Ahn","doi":"10.1016/j.amjms.2025.09.008","DOIUrl":"10.1016/j.amjms.2025.09.008","url":null,"abstract":"","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145088810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Association of Gustave Roussy immune score and the risk of in-hospital mortality in patients with acute respiratory distress syndrome: A retrospective cohort study from MIMIC-IV database.","authors":"Qiong Ji, Wei Liu","doi":"10.1016/j.amjms.2025.09.011","DOIUrl":"10.1016/j.amjms.2025.09.011","url":null,"abstract":"<p><strong>Background: </strong>There has been a lack of studies to describe the relationship between Gustave Roussy immune score (GRIm-s) and the risk of in-hospital mortality in patients with acute respiratory distress syndrome (ARDS) so far. This study aimed to investigate the relationship between GRIm-s and hospital mortality in patients with ARDS and to compare the predictive ability of GRIm-s with common scoring systems for predicting mortality risk based on MIMIC-IV database.</p><p><strong>Methods: </strong>GRIm-s was calculated based on albumin, neutrophil-to-lymphocyte ratio (NLR) and lactate dehydrogenase (LDH). The univariate and multivariate logistic regression analysis were used to explore association between GRIm-s and in-hospital mortality, with odds ratio (OR) and 95 % confidence intervals (CIs). The receiver operator characteristic (ROC) analysis was performed to verity the predictive power and the enhancement the predictive power of GRIm-s to NLR and sequential organ failure assessment (SOFA), simplified acute physiology score II (SAPSII) and confusion, uremia, respiratory rate, blood pressure, age ≥65 years (CURB-65), with area under the curve (AUC) and 95 %CI.</p><p><strong>Results: </strong>Totally 1238 eligible ARDS patients were included with the in-hospital mortality was 34.25 %. High GRIm-s was associated with higher risk of in-hospital mortality. The predictive value of GRIm-s was superior to NLR. GRIm-s can significantly improve the predictive power of a single score prediction system including SOFA, SAPSII, and CURB-65.</p><p><strong>Conclusions: </strong>High GRIm-s was associated with high risk of in-hospital mortality in ARDS patients. GRIm-s has a good predictive ability for the prognosis of ARDS patients.</p>","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145088816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Renxi Li, SeungEun Lee, Deyanira J Prastein, Stephen J Huddleston
{"title":"In-hospital isolated coronary artery bypass grafting outcomes in patients with psoriasis: a population-based National Inpatient Sample study from 2015-2021.","authors":"Renxi Li, SeungEun Lee, Deyanira J Prastein, Stephen J Huddleston","doi":"10.1016/j.amjms.2025.09.010","DOIUrl":"10.1016/j.amjms.2025.09.010","url":null,"abstract":"<p><strong>Background: </strong>Psoriasis is a chronic skin disease that shares common inflammatory pathways with atherosclerosis. Although psoriasis is known to increase risk of developing coronary artery disease, the impact of psoriasis on outcomes after coronary artery bypass grafting (CABG) remains less established. This study aimed to compare the in-hospital outcomes of isolated CABG between patients with and without psoriasis through a population-based analysis of a national database.</p><p><strong>Methods: </strong>Patients underwent CABG were selected from National Inpatient Sample from Q4 2015-2021. Patients with age <18 years and concomitant procedures were excluded. A 1:2 propensity-score matching was used to match demographics, socioeconomic status, primary payer status, hospital characteristics, comorbidities, and transfer/admission status between psoriasis and non-psoriasis patients. In-hospital outcomes were assessed.</p><p><strong>Results: </strong>There were 1,732 (0.95%) patients who underwent isolated CABG who had psoriasis. Patients with psoriasis were younger and more socioeconomically advantaged. After propensity-score matched to 3598 out of 191,175 non-psoriasis patients, patients with and without psoriasis had comparable in-hospital mortality rates (1.39% vs 1.03%, p = 0.27) and major adverse cardiovascular event (1.45% vs 1.86%, p = 0.31). Psoriasis patients had a slightly lower risk of venous thromboembolism (0.23% vs 0.67%, p = 0.04). All other in-hospital outcomes were comparable between psoriasis and non-psoriasis patients.</p><p><strong>Conclusions: </strong>The representation of psoriasis patients in CABG was lower than their prevalence in the general population. After propensity-score matching, outcomes for patients with and without psoriasis were comparable. Thus, despite the elevated cardiovascular risks associated with psoriasis, CABG may be as safe and as effective for these patients.</p>","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145088801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mortality trends for bacterial septicaemia in the United States (1999-2024): Age, sex disparities and the impact of the COVID-19 pandemic.","authors":"Camilla Mattiuzzi, Giuseppe Lippi","doi":"10.1016/j.amjms.2025.09.012","DOIUrl":"10.1016/j.amjms.2025.09.012","url":null,"abstract":"<p><strong>Background: </strong>Sepsis remains a significant public health challenge, with persistent mortality rates despite advancements in diagnosis and treatment. This study examined mortality trends for bacterial septicaemia in the US between 1999-2024.</p><p><strong>Methods: </strong>Mortality data were obtained from the National Center for Health Statistics, National Vital Statistics System, Provisional Mortality WONDER Online Database. Bacterial septicaemia-related deaths were identified using ICD-10 codes, and Poisson regression analysis was performed to assess trends across demographics.</p><p><strong>Results: </strong>Mortality for bacterial septicaemia declined from 1999 to 2012, showing a modest increase until 2019. A sharp rise occurred during the COVID-19 pandemic (2020-2022), with total deaths for bacterial septicaemia increasing by 21.2 % compared to the pre-pandemic period (17.4 % in females and 23.9 % in males). Mortality rates in males were consistently higher than in females throughout the study period. Poisson regression analysis did not reveal statistically significant long-term cumulative or sex-specific trends. Age-stratified analysis showed a sustained decline in mortality over time among children under 15 years, whereas mortality increased in adults in all age groups between 25 and 74 years. Age-stratified analysis excluding the early pandemic years showed a relative decline in mortality for bacterial septicaemia in those aged <1 to 24 years, a relative increase in the 45-74-year age group, and a stable trend in other age categories.</p><p><strong>Conclusions: </strong>Although cumulative mortality for bacterial septicaemia remained stable in the long term, rising deaths in middle-aged adults and pandemic-related increases highlight the need for reinforced prevention, timely diagnosis and accurate management strategies.</p>","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145088784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A multiple sclerosis review for the primary care physician.","authors":"William Meador, Helena Steen","doi":"10.1016/j.amjms.2025.09.007","DOIUrl":"10.1016/j.amjms.2025.09.007","url":null,"abstract":"<p><p>Multiple Sclerosis (MS) is a complex neurological condition that requires an interprofessional approach to manage effectively. Primary care providers (PCPs) play a vital role in the management of MS as they represent the first line providers who can quickly and accurately recognize disease activity or worsening, assist patients with monitoring of disease burden and adequately address comorbidities that drive disease activity. This is especially true considering access constraints to specialists for patients residing in smaller communities. This article reviews how PCPs can recognize new disease activity versus pseudorelapse, can assist with medication monitoring, can support patients' needs for imaging surveillance and can recognize the importance of managing comorbid illnesses. As many patients travel quite a distance to tertiary care centers for MS management, PCPs may be asked to assist with labwork monitoring or imaging support.</p>","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145058860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"In untreated non-diabetic subjects, obesity is accompanied by greater associations of blood viscosity with glucose and oxidative metabolism.","authors":"Fumihiro Tomoda, Hiroko Kurosaki, Hiroko Sugimori, Tsutomu Koike, Maiko Ohara, Atsumi Nitta, Koichiro Kinugawa","doi":"10.1016/j.amjms.2025.09.006","DOIUrl":"10.1016/j.amjms.2025.09.006","url":null,"abstract":"<p><strong>Background: </strong>The influences of blood viscosity on metabolism and the peripheral circulation have not been fully explored in obesity. We evaluated the impact of obesity on the associations of blood viscosity with those two systems in non-diabetic subjects.</p><p><strong>Methods: </strong>In 119 obese and 163 non-obese non-diabetic subjects, blood viscosity was measured using a falling-ball microviscometer. Homeostasis model assessment of insulin resistance (HOMA-IR) and blood lactate were also determined as indices for insulin resistance and anaerobic metabolism, respectively.</p><p><strong>Results: </strong>Blood viscosity was significantly greater in the obese group than in the non-obese group (4.25±0.46 versus 4.14±0.44 mPa·S, p = 0.032). Blood viscosity was independently positively associated with log HOMA-IR and log blood lactate in the obese group, but not in the non-obese group. In all subjects, the body mass index status (i.e., non-obese or obese = 0 or 1) × blood viscosity interaction was significantly associated with log HOMA-IR and log blood lactate (partial r = 0.130, p = 0.029 and partial r = 0.173, p = 0.013). Thus, greater influences of blood viscosity on glucose and oxidative metabolism were observed in the obese group than the non-obese group. However, only approximately 9 to 11 % of the variance in blood viscosity was attributable to differences in log HOMA-IR or log blood lactate in the obese group. Contrastingly, blood viscosity did not relate with blood pressure in either group.</p><p><strong>Conclusions: </strong>In non-diabetic obesity, blood viscosity elevates, and such hemorheological change could at least partially contribute to the aggravations of insulin resistance and anaerobic metabolism.</p>","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145042817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yuval Avidan, Amir Aker, Razi Khoury, Baruch Weizman, Sameer Kassem
{"title":"How often is multifocal atrial tachycardia mistaken for atrial fibrillation in the emergency department?","authors":"Yuval Avidan, Amir Aker, Razi Khoury, Baruch Weizman, Sameer Kassem","doi":"10.1016/j.amjms.2025.09.003","DOIUrl":"10.1016/j.amjms.2025.09.003","url":null,"abstract":"<p><strong>Objective: </strong>Multifocal atrial tachycardia (MAT), characterized by an irregularly irregular rhythm, is often regarded as a clinical imitator of atrial fibrillation (AF). We aimed to evaluate the prevalence of MAT misclassification as AF in the emergency department (ED) setting.</p><p><strong>Methods: </strong>A retrospective analysis of 1828 ECGs from patients discharged with AF diagnoses over five years. All tracings were independently reviewed by three blinded cardiologists.</p><p><strong>Results: </strong>MAT was identified in one case (0.05 %). Other misclassifications included atrial flutter (7.9 %), supraventricular tachyarrhythmias (1.6 %), and sinus rhythm with conduction disturbances, artifacts, or ectopy (1.0 %).</p><p><strong>Conclusions: </strong>Misdiagnosis of MAT as AF in the ED is rare. However, other diagnostic errors remain relatively common, underscoring the need for careful rhythm evaluation.</p>","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145017055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shivmurat Yadav, Stavros Stavrakis, Constance R Chu, Mary Beth Humphrey
{"title":"Vagus nerve stimulation as a novel therapeutic approach for musculoskeletal diseases.","authors":"Shivmurat Yadav, Stavros Stavrakis, Constance R Chu, Mary Beth Humphrey","doi":"10.1016/j.amjms.2025.09.005","DOIUrl":"10.1016/j.amjms.2025.09.005","url":null,"abstract":"<p><p>Vagus nerve stimulation (VNS) has gained significant attention as a therapy for various medical conditions due to its ability to modulate chronic diseases, pain, and inflammation. VNS delivered by an implanted device is FDA approved for severe epilepsy and refractory depression. VNS delivered with implantable devices or transcutaneous methods are now being studied in several musculoskeletal diseases including osteoarthritis, rheumatoid arthritis, systemic lupus erythematosus, and fibromyalgia. VNS activates the neuroimmune axis including the cholinergic anti-inflammatory pathway (CAP), suppressing inflammation and reducing pain. Here, we review the pathophysiology of VNS and the outcomes from clinical trials in musculoskeletal diseases. We address the limitations of these studies, including the inconsistent use of physiological biomarkers, such as heart rate variability, to ensure that VNS is engaging the vagus nerve. More studies are required to reveal the full potential of VNS for pain reduction and disease modification.</p>","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145008628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mark Cromer, Kaitlyn Domning, Rebecca Sullivan, Mahmoud Aryan, Erin Petrie, Sujan Ravi, Mark Beasley, Mohamed Shoreibah
{"title":"The risk of gastrointestinal bleeding with dual antiplatelet therapy in cirrhotics undergoing liver transplant evaluation.","authors":"Mark Cromer, Kaitlyn Domning, Rebecca Sullivan, Mahmoud Aryan, Erin Petrie, Sujan Ravi, Mark Beasley, Mohamed Shoreibah","doi":"10.1016/j.amjms.2025.09.001","DOIUrl":"10.1016/j.amjms.2025.09.001","url":null,"abstract":"<p><strong>Background: </strong>Metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis is now the second leading indication for liver transplantation (LT) worldwide and is associated with increased risk of cardiovascular events before and after LT. Cirrhotics who undergo left heart catheterization (LHC) with coronary artery stenting for LT evaluation require dual antiplatelet therapy (DAPT). Data regarding the safety, risk of gastrointestinal (GI) bleeding, and mortality risk of cirrhotics receiving DAPT is limited.</p><p><strong>Aim: </strong>The objective of this study was to assess the risk of and outcomes related to GI bleeding in cirrhotics undergoing LT evaluation who received DAPT.</p><p><strong>Methods: </strong>We conducted a retrospective review of adults with decompensated cirrhosis who underwent a LHC as part of LT evaluation between 2014 and 2021.</p><p><strong>Results: </strong>A total of 291 patients were included. Thirty-three underwent LHC with coronary artery stenting and received DAPT, while 258 underwent LHC without intervention and received no DAPT. When comparing the DAPT and control groups, there were no significant differences in the following: GI bleeding on univariate analysis (9.09% vs 14.73%; p= 0.381) and multivariate analysis (odds ratio = 0.579; 95% confidence interval = 0.168 - 1.992; p = 0.386); recurrent GI bleeding (0% vs 4.26%; p = 0.227); variceal hemorrhage (3.03% vs 4.65%; p = 0.671); liver transplanation (30.30% vs 44.19%; p = 0.129); or 12-month mortality following GI bleeding (3.03% vs 5.81%; p = 0.509).</p><p><strong>Conclusions: </strong>Use of DAPT was not associated with an increased risk of GI bleeding or bleeding-related complications in decompensated cirrhotics with coronary artery disease undergoing LT evaluation.</p>","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145008636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}